Rising Biosciences, Inc. Develops Groundbreaking Oral
THC/CBD Delivery Capsule
Cannophen; Nears Completion on MMJ
Laboratory in Ohio
Sandusky, OH
-- January 18, 2018 -- InvestorsHub NewsWire
-- Rising
India, Inc.'s (OTC:
RSII) -- Rising Biosciences, Inc., a
research and development company focusing on oral and topical
pharmaceuticals with strict standards set forward by the
pharmaceutical compounding industry, is pleased
to announce that its laboratory in Ohio is close to completion in
line with the State of Ohio issuing
MMJ licenses.
"Now that
Ohio is beginning to issue licenses, we plan on being fully
operational in our medical marijuana laboratory, which will focus
on research, development, licensing and manufacturing of innovative
products in the Cannabis space dedicated to serving patients with
the highest standards," states COO Arthur Hall.
"We are also
thrilled to announce that included in a line of medical cannabis
products, the company is debuting
Cannophen, a
revolutionary product we've been developing for some time
now. Cannophen is an oral
capsule with laboratory controlled metered dosing that can be
blended in exacting ratios of THC, CBD and strain specific
tirpenes.
It is easily digestible and fast acting and designed for patients
that do not want to smoke/vape
or use
off-tasting tinctures. This allows patients to take their medicine
by swallowing a flavorless capsule, just like any other oral
medication. We are also pleased to announce a new MMJ version of
the TSW pain cream
containing Cannabidiol
(CBD)."
Hall adds,
"There has never been any proper way to dose with the above said
methods. We have developed Cannophen
using the
strictest quality and control standards and methods set forth in
the pharmacy compounding industry using experienced chemists and
veteran pharmacists."
As well,
Rising Biosciences is nearing completion on its FDA testing of
the TSW (This Sh**
Works) pain cream
products.
"We've also
had stellar feedback from those that received trial samples of the
Clinical Strength Scar Peptide Serum and we now move into the next
phase of production," concludes Hall.
"Rising Biosciences Inc. along with PAO Group Inc.
helping reduce the grip of opiods on America
through the responsible use of cannabis"
$RSII
on Twitter for LIVE company updates! www.twitter.com/risingindiausa
Forward-Looking
Statements: Certain statements in this news release may contain
forward-looking information within the meaning of Rule 175 under
the Securities Act of 1933 and Rule 3b-6 under the Securities
Exchange Act of 1934, and are subject to the safe harbor created by
those rules. All statements, other than statements of fact,
included in this release, including, without limitation, statements
regarding potential future plans and objectives of the company, are
forward-looking statements that involve risks and uncertainties.
There can be no assurance that such statements will prove to be
accurate and actual results and future events could differ
materially from those anticipated in such statements. Technical
complications, which may arise, could prevent the prompt
implementation of any strategically significant plan(s) outlined
above. The Company undertakes no duty to revise or update any
forward- looking statements to reflect events or circumstances
after the date of this release.